Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Merve Celik Guler

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Expert Review of Endocrinology & Metabolism|November 5, 2025
Advances of pharmacological therapies in lipodystrophy syndromes: current evidence and future directionsOzge Besci, Merve Celik Guler, Maria Cristina Foss-Freitas, et al.
Clinical Endocrinology|July 17, 2025
Potential Impact of Parental Origin of Inheritance on the Clinical Presentation of Familial Partial Lipodystrophy Type 2 SyndromeDonatella Gilio, Ozge Besci, Natália Rossin Guidorizzi, et al.
Diabetes Care|March 10, 2025
Metabolic Improvements With Tirzepatide in Lipodystrophy: A Novel Option?Rasimcan Meral, Merve Celik Guler, Diarratou Kaba, et al.
Medrxiv : the Preprint Server for Health Sciences|January 13, 2025
Tirzepatide for LipodystrophyRasimcan Meral, Merve Celik Guler, Diarratou Kaba, et al.
The Journal of Clinical Endocrinology and Metabolism|October 16, 2023
Deciphering the Clinical Presentations in LMNA-related Lipodystrophy: Report of 115 Cases and a Systematic ReviewOzge Besci, Maria Christina Foss de Freitas, Natália Rossin Guidorizzi, et al.
Diabetes, Obesity & Metabolism|March 22, 2023
Clinical features of generalized lipodystrophy in Turkey: A cohort analysisIlgin Yildirim Simsir, Beyhan Tuysuz, Mehmet Nuri Ozbek, et al.
The Journal of Clinical Investigation|November 11, 2025
Altered lipid metabolism and inflammatory programs associate with adipocyte loss in familial partial lipodystrophy 2Jessica N Maung, Rebecca L Schill, Akira Nishii, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Expert Review of Endocrinology & Metabolism|November 5, 2025
Advances of pharmacological therapies in lipodystrophy syndromes: current evidence and future directionsOzge Besci, Merve Celik Guler, Maria Cristina Foss-Freitas, et al.
Clinical Endocrinology|July 17, 2025
Potential Impact of Parental Origin of Inheritance on the Clinical Presentation of Familial Partial Lipodystrophy Type 2 SyndromeDonatella Gilio, Ozge Besci, Natália Rossin Guidorizzi, et al.
Diabetes Care|March 10, 2025
Metabolic Improvements With Tirzepatide in Lipodystrophy: A Novel Option?Rasimcan Meral, Merve Celik Guler, Diarratou Kaba, et al.
Medrxiv : the Preprint Server for Health Sciences|January 13, 2025
Tirzepatide for LipodystrophyRasimcan Meral, Merve Celik Guler, Diarratou Kaba, et al.
The Journal of Clinical Endocrinology and Metabolism|October 16, 2023
Deciphering the Clinical Presentations in LMNA-related Lipodystrophy: Report of 115 Cases and a Systematic ReviewOzge Besci, Maria Christina Foss de Freitas, Natália Rossin Guidorizzi, et al.
Diabetes, Obesity & Metabolism|March 22, 2023
Clinical features of generalized lipodystrophy in Turkey: A cohort analysisIlgin Yildirim Simsir, Beyhan Tuysuz, Mehmet Nuri Ozbek, et al.
The Journal of Clinical Investigation|November 11, 2025
Altered lipid metabolism and inflammatory programs associate with adipocyte loss in familial partial lipodystrophy 2Jessica N Maung, Rebecca L Schill, Akira Nishii, et al.
Pageof 1